EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of baicalein-modified carbon nanodots in cancer therapy: A narrative review

Nasihah Mohd Zahid, Noor Nabilah Talik Sisin, Mochamad Zakki Fahmi, Nor Fazila Che Mat

Nano Biomedicine and Engineering · 2026-12 · 18 (4) · 100076

DOI: 10.1016/j.nbe.2026.100076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Biomedicine and Engineering, 2026-12. Verfasst von Nasihah Mohd Zahid und 3 weiteren Autor:innen. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universiti Sains Malaysia.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Baicalein is a multi-target flavonoid with broad preclinical anticancer activity, but its clinical translation is limited by poor aqueous solubility, chemical instability, rapid metabolism, and low bioavailability, restricting sustained tumor exposure. Carbon nanodots (CDs) are ultrasmall, surface-tunable, intrinsically fluorescent nanoparticles investigated for drug delivery and theranostic applications. This narrative review integrates baicalein’s anticancer mechanisms, delivery barriers, and CD-based formulation strategies to establish mechanistically grounded design principles for baicalein–CDs systems. A structured search of PubMed and Google Scholar (1988–January 2026) was conducted using baicalein-, carbon nanodot-, and cancer-related keywords, followed by thematic synthesis and qualitative appraisal of nanomaterial characterization and experimental rigor. Baicalein–CDs systems can be developed through physical loading, covalent conjugation, or hybrid approaches. Their performance is influenced by nano–bio interface interactions, including π–π stacking, hydrogen bonding, electrostatic interactions, and protein corona formation, which affect stability, drug retention, release behavior, and cellular uptake. Existing studies demonstrate successful baicalein loading or conjugation and report promising in vitro anticancer-related effects. However, most evidence remains preliminary, with limited serum-stability evaluation, inconsistent benchmarking, inadequate quantification of drug association, and insufficient in vivo biodistribution and safety data. This review proposes a minimum translational framework emphasizing standardized physicochemical characterization, stability and release studies in biologically relevant media, and pharmacokinetic, biodistribution, and toxicity evaluations aligned with chemistry, manufacturing and controls (CMC) principles. Overall, baicalein–CDs represent a promising but early-stage nanomedicine platform requiring stronger mechanistic and translational validation.

Förderung

  • Universiti Sains Malaysia

Zitieren

APA

Zahid, N. M., Sisin, N. N. T., Fahmi, M. Z., & Mat, N. F. C. (2026). Role of baicalein-modified carbon nanodots in cancer therapy: A narrative review. Nano Biomedicine and Engineering, 18(4), 100076. https://doi.org/10.1016/j.nbe.2026.100076

Vancouver

Zahid NM, Sisin NNT, Fahmi MZ, Mat NFC. Role of baicalein-modified carbon nanodots in cancer therapy: A narrative review. Nano Biomedicine and Engineering. 2026;18(4):100076. doi:10.1016/j.nbe.2026.100076

BibTeX
@article{Zahid2026,
  author = {Zahid, Nasihah Mohd and Sisin, Noor Nabilah Talik and Fahmi, Mochamad Zakki and Mat, Nor Fazila Che},
  title = {Role of baicalein-modified carbon nanodots in cancer therapy: A narrative review},
  journal = {Nano Biomedicine and Engineering},
  year = {2026},
  volume = {18},
  number = {4},
  pages = {100076},
  doi = {10.1016/j.nbe.2026.100076}
}
Kostenlos starten →